Rocket Lab’s Near-50% Rebound Is Defying a Wave of Price-Target Cuts
Rocket Lab stock has surged 50% despite five Wall Street firms cutting price targets. Record backlog & Neutron demand offer counterargument.
Follow the latest Rocket Lab Corporation (RKLB) news and market headlines alongside the live RKLB price. Stay informed on what's moving RKLB.
Rocket Lab stock has surged 50% despite five Wall Street firms cutting price targets. Record backlog & Neutron demand offer counterargument.
Rocket Lab (NASDAQ:RKLB) has outperformed the market over the past 5 years by 23.11% on an annualized basis producing an average annual return of 33.15%. Currently, Rocket Lab has a market capitalization of $44.52
Rocket Lab's twin ESCAPADE spacecraft (Blue and Gold) successfully completed trans-Mars injection burns on November 7-9, 2026, achieving over 99% accuracy in autonomous 10-minute engine firings. The spacecraft are now on course to enter Mars orbit in September 2027, with science operations beginning in 2028. This milestone demonstrates Rocket Lab's capabilities in deep-space mission support and spacecraft propulsion systems.
Rocket Lab (RKLB) has outperformed its aerospace-defense industry peers with a 23.5% gain over the past year, driven by strong revenue growth (66.4% YoY), record backlog of $3.57 billion, and expanding spacecraft manufacturing. However, the stock trades at a significant premium valuation (29.91X forward P/S vs. 7.01X industry average), faces continued losses ($174M in 9M 2026), and execution risks with Neutron rocket delays. New investors should wait for better entry points, while current holders may stay invested given strong liquidity and low debt levels.
Rocket Lab reported Q3 revenues of $267.83M (73% YoY growth, beating estimates) but posted a wider-than-expected loss of 7 cents per share. The company secured $1B in new launch contracts, boosting backlog to $3.57B, with improved pricing power. However, Neutron's first launch shifted to 2027 due to manufacturing defects. The pending Iridium acquisition is fully financed with shareholder approval, though regulatory approval remains pending. Cash flow remains pressured despite positive GAAP operating cash flow of $7.2M.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to RKLB, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.